Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
21 studies found for:    NIAID | Open Studies | tuberculosis
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Training Protocol on the Natural History of Tuberculosis
Condition: Tuberculosis
Intervention:
2 Recruiting Effect of Filarial Infection on Immune Responses in Latent Tuberculosis
Conditions: Tuberculosis;   Filariasis
Intervention:
3 Not yet recruiting NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
Condition: Tuberculosis
Interventions: Drug: Moxifloxacin;   Drug: Pyrazindamide;   Drug: Rifampicin;   Drug: Isonizaid
4 Not yet recruiting Using Biomarkers to Predict TB Treatment Duration
Condition: Tuberculosis
Interventions: Procedure: blood draw;   Radiation: PET/CT;   Procedure: induced sputum
5 Recruiting Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance
Condition: Tuberculosis
Intervention:
6 Recruiting Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection
Condition: Latent Tuberculosis Infection
Intervention:
7 Recruiting DNA Sequencing of MDR TB in Eastern Siberia
Conditions: Tuberculosis;   HIV
Intervention:
8 Not yet recruiting Evaluating the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-Infected and HIV-1-Uninfected Pregnant and Postpartum Women With Latent Tuberculosis Infection
Condition: Tuberculosis
Interventions: Drug: Rifapentine (RPT);   Drug: Isoniazid (INH);   Dietary Supplement: Pyridoxine (vitamin B6)
9 Recruiting Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Bedaquiline;   Drug: Delamanid;   Drug: Dolutegravir
10 Not yet recruiting Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in HIV-Infected and HIV-Uninfected Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis
Conditions: Tuberculosis;   HIV Infections
Intervention: Drug: Bedaquiline
11 Recruiting Challenge Model for Assessment of Human TB Immunity
Condition: Tuberculosis
Intervention: Biological: BCG TICE strain
12 Recruiting Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)
Condition: Tuberculosis
Interventions: Behavioral: Community-based intervention;   Other: Standard of care
13 Recruiting High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)
Condition: Tuberculosis
Interventions: Drug: Isoniazid;   Dietary Supplement: Vitamin B6
14 Recruiting Evaluating the Safety, Tolerance, and Pharmacokinetics of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in Children Infected With HIV and TB
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Raltegravir
15 Recruiting PK Study of Rifampicin Interactions With DMPA and Efaviranz in TB
Conditions: HIV-1 Infection;   Tuberculosis
Intervention: Drug: depot medroxyprogesterone acetate
16 Recruiting Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa
Conditions: Latent Tuberculosis;   HIV
Intervention: Device: QGIT
17 Recruiting Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa
Condition: Tuberculosis
Intervention: Other: Active TB case finding
18 Recruiting Test and Treat TB: A Proof of Concept Trial in South Africa
Condition: Tuberculosis
Intervention: Other: Test-and-Treat TB
19 Recruiting Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB
Condition: Tuberculosis, Multidrug-Resistant
Interventions: Drug: Levofloxacin;   Drug: Optimized background regimen (OBR)
20 Recruiting A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes
Conditions: MDR-TB;   HIV
Intervention: Other: NCM-Plus

   Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.